InflaRx (IFRX) Change in Inventory (2023 - 2025)
InflaRx's (IFRX) quarterly Change in Inventory came in at $5.9 million in Q4 2025, up 95.81% year-on-year from $3.0 million in Q4 2024, and little changed quarter-over-quarter from $5.9 million in Q3 2025.
InflaRx (IFRX) Change in Inventory (2023 - 2025) Analysis & Trends
InflaRx has disclosed Change in Inventory across 3 years of filings, most recently posting $5.9 million for Q4 2025.
- Change in Inventory for Q4 2025 came in at $5.9 million, up 95.81% year-over-year; the trailing twelve-month figure through Dec 2025 was $8.8 million (up 84.45% YoY), and the FY2025 annual result was $8.0 million, up 68.09% from the prior year.
- Change in Inventory came in at $5.9 million for Q4 2025 at InflaRx, roughly flat from $5.9 million in the prior quarter.
- In the past five years, Change in Inventory ranged from a high of $5.9 million in Q3 2025 to a low of -$10.5 million in Q4 2023.
- The 3-year median for Change in Inventory is $630166.0 (2023), against an average of $1.0 million.
- Peak annual rise in Change in Inventory reached 7332.55% in 2025, while the deepest fall reached 99.3% in 2025.
- InflaRx's Change in Inventory stood at -$10.5 million in 2023, then jumped by 128.8% to $3.0 million in 2024, then jumped by 95.81% to $5.9 million in 2025.
- The last three Change in Inventory figures came in at $5.9 million (Q4 2025), $5.9 million (Q3 2025), and $5.7 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | 51,468.00 |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | - |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | 97.70 Mn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | - |
| 10 | InflaRx | 764.68 Mn | 764.68 Mn | 10,877.40 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 5.90 Mn |
| Dec 31, 2025 | 5.90 Mn |
| Sep 30, 2025 | 5.93 Mn |
| Sep 30, 2025 | 5.93 Mn |
| Jun 30, 2025 | 5.70 Mn |
| Jun 30, 2025 | 5.70 Mn |
| Mar 31, 2025 | 2,414.07 |
| Mar 31, 2025 | 2,414.07 |
| Dec 31, 2024 | 3.01 Mn |
| Dec 31, 2024 | 3.01 Mn |
| Sep 30, 2024 | -81,972.20 |
| Sep 30, 2024 | -81,972.20 |
| Jun 30, 2024 | 1.51 Mn |
| Jun 30, 2024 | 1.51 Mn |
| Mar 31, 2024 | 346,725.39 |
| Mar 31, 2024 | 346,725.39 |
| Dec 31, 2023 | -10.47 Mn |
| Dec 31, 2023 | -10.47 Mn |
| Sep 30, 2023 | -1.15 Mn |
| Sep 30, 2023 | -1.15 Mn |